)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
AEON Biopharma (AEON) investor relations material
AEON Biopharma Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary19 Dec, 2025
Executive summary
Special Meeting called to approve key financing and capital structure proposals to fund ABP-450 biosimilar development and commercialization efforts, including a PIPE financing, convertible note exchange, and equity plan amendment.
Company is pursuing a Section 351(k) biosimilar regulatory pathway for ABP-450, shifting from prior clinical programs after Phase 2 migraine trials did not meet endpoints.
As of September 30, 2025, cash and cash equivalents were $5.9 million, with an accumulated deficit of $433.7 million; management has concluded there is substantial doubt about the ability to continue as a going concern without additional funding.
Recent financings include a $15 million convertible note from Daewoong, a $18.3 million public offering, and a $6 million PIPE, with further closings subject to shareholder approval.
NYSE American has granted the company until August 3, 2026, to regain compliance with minimum stockholders' equity requirements.
Voting matters and shareholder proposals
Four proposals: (1) PIPE Financing Proposal for issuance of shares and warrants, (2) Exchange Proposal for convertible note exchange with Daewoong, (3) Equity Plan Proposal to increase shares under the incentive plan, (4) Adjournment Proposal to solicit additional proxies if needed.
Board recommends voting FOR all proposals; PIPE and Exchange Proposals are interdependent and require mutual approval.
Shareholders of record as of December 15, 2025, are eligible to vote; quorum is 33.34% of voting power.
Board of directors and corporate governance
Board composition includes a Daewoong designee as Class III director; recent CEO transition with Robert Bancroft appointed in April 2025.
Board and committees oversee compensation, audit, and governance; director compensation includes cash retainers and equity awards.
Board has adopted a clawback policy for executive compensation in line with SEC and NYSE rules.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next AEON Biopharma earnings date
Q4 202527 Mar, 2026
Next AEON Biopharma earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
AEON Biopharma Inc. is a biopharmaceutical company focused on the development of therapeutic applications for botulinum toxin. The company aims to advance treatments for a range of medical conditions, particularly in neurology and related therapeutic areas. AEON Biopharma is engaged in clinical research and regulatory processes to expand the use of botulinum toxin beyond aesthetic applications. The company is headquartered in Irvine, California, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage